Stock analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock.
China Pharma Stock Up 7.6 %
Shares of NYSE CPHI opened at $0.20 on Friday. China Pharma has a 52 week low of $0.17 and a 52 week high of $1.77. The stock has a 50 day moving average price of $0.24 and a 200 day moving average price of $0.32. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.89 and a quick ratio of 0.25.
China Pharma (NYSE:CPHI – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.93 million during the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Further Reading
- Five stocks we like better than China Pharma
- What Investors Need to Know About Upcoming IPOs
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- What Are the FAANG Stocks and Are They Good Investments?
- MarketBeat Week in Review – 8/12 – 8/16
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
